Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
benzodiazepine |
| gptkbp:approvedBy |
some European countries
|
| gptkbp:ATCCode |
N05BA11
|
| gptkbp:CASNumber |
524-52-5
|
| gptkbp:eliminationHalfLife |
12 hours
|
| gptkbp:hasMolecularFormula |
C16H13ClN2O
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pinazepam
|
| gptkbp:isMetabolizedTo |
desmethyldiazepam
|
| gptkbp:isNotApprovedIn |
gptkb:United_States
|
| gptkbp:IUPACName |
7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:PubChem_CID |
4765
DB01585 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
muscle relaxation
drowsiness impaired coordination |
| gptkbp:usedFor |
benzodiazepine
sedative |
| gptkbp:wasPatentedIn |
1969
|
| gptkbp:bfsParent |
gptkb:N05BA
|
| gptkbp:bfsLayer |
7
|